| Category | Min Lots | Shares | Amount |
|---|---|---|---|
| Retail (sNII) | 1 | 1,200 | ₹1,16,400 |
| HNI / NII | 2 | 2,400 | ₹2,32,800 |
| Category | Sub (×) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 20,67,600 (46.47%) | — | ₹2,005.57 Cr |
| NII / HNI (Total) | — | 6,55,200 (14.72%) | — | ₹635.54 Cr |
| Retail Investors | — | 14,98,800 (33.68%) | — | ₹1,453.84 Cr |
| Total ** | — | 44,49,600 (100.00%) | — | ₹43,161.12 Cr |
| Market Maker * | — | 2,28,000 (5.12%) | — | ₹22.12 Cr |
| Metric | 31 Dec 2023 | 31 Mar 2023 | 31 Mar 2023 |
|---|---|---|---|
| Revenue | 6217.83 | 6186.60 | 5954.20 |
| PAT | 6217.83 | 6217.83 | 410.50 |
| EBITDA | — | — | — |
| Net Worth | 2277.15 | 1502.21 | 999.38 |
| Total Assets | 5869.09 | 4664.72 | 3479.86 |
| Reserves | 1198.39 | 891.50 | 891.50 |
| Borrowings | 460.66 | 409.69 | 312.54 |
Incorporated in June 1998, Quest Laboratories Limited is a pharmaceutical company manufacturing a range of antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more.
The company operates in the domestic market across twelve (12) states and two (2) union territories. These include Uttar Pradesh, Madhya Pradesh, Maharashtra, Delhi, Jharkhand, Assam, Karnataka, Jammu & Kashmir, Rajasthan, West Bengal, Gujarat, Telangana, Haryana, and Bihar.
The manufacturing unit of the company is located in Dhar, Madhya Pradesh.
The company holds WHO Schedule M GMP and GLP certifications, as well as ISO/IEC 17025:2017 and ISO 9001:2015 certifications.
By December 31st, 2023, the company employs 83 individuals to lookafter various aspects of its manufacturing operations, including production, quality control, technical and engineering support services, inventory management, administration, accounting, and other functions such as storage, packing, and dispatch.